We investigated the role of tumor necrosis factor alpha (TNF-a1) in human peripheral monocytes infected with Legionella pneumophila in vitro. Exogenous TNF-a significantly inhibited the intracellular multiplication of the bacterium. This effect was concentration and time dependent and was abrogated by anti-TNF antibodies. TNF-ac levels in the culture supernatants were low but were enhanced by the addition of gamma interferon. When monocytes were cultured and infected in the presence of pentoxyphilline, a potent inhibitor of TNF-a synthesis, the intracellular bacterial growth was enhanced. The effect of pentoxyphilline was concentration and time dependent and was due to the inhibition of TNF-a production, as shown by Northern (RNA) blot hybridization of total RNA. In addition, the pentoxyphilline partially abolished the inhibitory effect of gamma interferon on bacterial intracellular multiplication. These results suggest that gamma interferon inhibits, at least partially, the intracellular multiplication of L. pneumophila by enhancing TNF-at synthesis.
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Tumor necrosis factor (TNF), an immunostimulatory cytokine, has multiple biological properties (antitumor effect, cytostatic and cytolytic effects, and weight loss induction) (7) . TNF has been reported to enhance the phagocytic activity of human polymorphonuclear neutrophils and to mediate their adherence to endothelial cells (20) , to mediate natural cytotoxic cell activity (17) , and to stimulate the antiparasitic activity of eosinophils (21) . TNF also participates in the cytokine cascade during the immune response (10) , acting synergistically with gamma interferon (IFN--y). TNF and IFN--y have been found to activate macrophages and enhance their antitumor and antimicrobial activities (12) .
Legionella pneumophila is a gram-negative facultative intracellular pathogen that causes pneumonia (11) . L. pneumophila can infect human monocytes and alveolar macrophages in vitro and in vivo (15) . The host may limit infection to survive. Intracellular multiplication can be inhibited by IFN--y activation of alveolar macrophages (16 Co2.
Cytokine assays. TNF activity was detected with 5 x 104 L-929 cells per well seeded in 96-well microtiter plates and suspended in 0.1 ml of RPMI 1640 medium containing 10% fetal calf serum. Actinomycin D (Sigma) at a final concentration of 1 ,ug/ml was added before the sample dilutions (0.1 ml). The cells were incubated at 37°C for 18 h and then extensively washed in Hanks' balanced salt solution (GIBCO). Adherent cells were stained for 10 min with crystal violet (0.2% in 2% ethanol) and washed with water, and 0.1 ml of 1% sodium dodecyl sulfate (SDS) was added to each well to solubilize the stained cells. The A550 of each well was read. Percent cytotoxicity was defined as the relative absorbance of the test sample versus that of the control (medium only) wells, as follows: % cytotoxicity = {[1 -absorbance of samples/absorbance of control]} x 100. The cytotoxicity titer (units per milliliter) was defined as the dilution of test sample that caused 50% cytotoxicity.
TNF-a and interleukin-6 (IL-6) production in the culture supernatants were also measured, using an enzyme immunoassay (Medgenix, Brussels, Belgium), and results were expressed as picograms per milliliter.
RNA preparation and analysis. 
RESULTS
Exogenous TNF-oi inhibits intracellular multiplication of L. pneumophila in human peripheral monocytes in a concentration-and time-dependent fashion. We incubated human peripheral monocytes with TNF-a (102 to 104 U/ml) for 1 h before L. pneumophila infection and assayed the cultures for bacterial CFU after 3 days. As shown in Table 1, L. pneumophila multiplication was inhibited in human 4periph-eral monocytes treated with TNF-a at 103 and 10 U/ml, while no significant inhibition was observed at lower TNF-a concentrations (three experiments). The results obtained with different times (24 h, 1 h, and 30 min) of monocyte incubation with 103 U of TNF-a per ml before infection were similar, and the intracellular multiplication of L. pneumophila was found to be consistently inhibited. However, when the monocytes were incubated with TNF-a 30 min after Legionella infection, there was no significant inhibition of bacterial multiplication, even when higher TNF-a concentrations were used (104 U/ml; data not shown).
To examine whether the action of TNF-a on the multiplication of L. pneumophila was specific, we attempted to inhibit its effect with a monoclonal anti-TNF antibody. When monocytes were incubated with 103 U of TNF-a per ml plus a monoclonal anti-TNF antibody (diluted 1/10) 1 h before infection, the effect of TNF-a on L. pneumophila multiplication was significantly reduced ( Table 2) . A similar reduction was observed when TNF-a and the anti-TNF antibody were added to the cell culture 24 h before infection.
In all experiments, the effect of exogenous IFN--y (0.01 ,ug/ml) was studied in parallel. IFN-,y was a strong inhibitor of intracellular multiplication even when added 30 min after infection. The addition of both TNF-a and IFN--y did not potentiate the inhibitory effect of IFN--y further (Table 2) .
TNF-a production during L. pneumophila infection in vitro. TNF-a and IL-6 production by human monocytes infected with L. pneumophila was determined by biological assays and enzyme immunoassays in the culture supernatants at various periods after infection. A moderate increase in TNF-a production was observed in the culture supernatants 24, 48, and 72 h after infection, while the addition of 10 ,ug of lipopolysaccharide (LPS) per ml resulted in significant TNF-a production (Table 3) . (and IL-1) production was significantly increased during this period (data not shown). the biological method for TNF-at production (8, 14 , and 17 pg of TNF-a per ml at 24, 48, and 72 h after infection, respectively). Since the presence of TNF-a in the culture supematants was not significantly increased during the infection, we studied TNF-ao production after the addition of IFN--y to the L. pneumophila-infected monocytes: TNF-a production in the culture supernatants was consistently increased (Table 3) . PTX, a potent inhibitor of endogenous TNF-ar production, enhanced intracellular multiplication. When a monoclonal anti-TNF-at antibody (diluted 1/10) was added to the monocyte cultures before or after infection, bacterial growth was not modified after 3 days of culture (data not shown). We therefore studied the effect of PTX, a potent inhibitor of endogenous TNF-a production (but not of other cytokines such as IL-lp and IL-6), on bacterial multiplication. Cultures were infected in the presence or absence of PTX and were assayed for Legionella CFU after 3 days. In the presence of PTX (10 and 102 ,ug/ml, added to the culture 2 h before infection), L. pneumophila multiplication was consistently increased. At lower PTX concentrations (1 ,ug/ml) and when PTX was added to the monocyte culture after Legionella infection, the bacterial multiplication was similar to that in control human monocytes (culture medium only) ( Table 4 ). When total RNA was extracted from the cells infected in the presence of PTX and assessed by Northern (RNA) blot hybridization with probes specific for TNF-ot (and IL-6 as a control), we found significant inhibition of TNF-ot RNA synthesis. The synthesis of IL-6 RNA was not modified (Fig. 1) . IFN-y inhibits intracellular multiplication of L. pneumophila by enhancing endogenous TNF-a production. Infection was performed in the presence of PTX plus IFN-y, and the cultures were assayed for Legionella CFU after 3 days. In the presence of IFN-y (200 U) and PTX (10 and 102 ,ug/ml), added to the cell culture 2 h before infection, L. pneumophila multiplication was increased relative to cultures infected in the presence of IFN--y alone. PTX at 10 ,.g/ml was a more potent inhibitor of the IFN--y effect than at the higher concentration (102 ,ug/ml). At a lower PTX concentration (1 jig/ml), we found no interference with the IFN-,y effect on bacterial multiplication (Table 4 ). The addition of PTX to monocyte cultures infected in the presence of IFN--y resulted in inhibition of TNF-ot RNA expression but not of IL-6 RNA expression.
DISCUSSION
The alveolar macrophage is the principal target of L. pneumophila, which destroys these cells. Since L. pneumophila is a facultative intracellular bacterium, the host controls the infection by cell-mediated immune responses and by activating macrophages and rendering them resistant to intracellular multiplication. Macrophages can be activated by various lymphokines, among which IFN-,y is considered the most important. Activation of human resident macrophages by IFN-,y and enhanced antimicrobial activity against L. pneumophila have been described previously (16) . This enhanced antimicrobial activity can also concern many other intracellular pathogens (12, 14) . Production of TNF has been reported to occur in lung lavage fluid during L. pneumophila infection (3). In addition, synergy and a cooperative effect between IFN-y and TNF have been described (12) . We tested the hypothesis that TNF production during L. pneumophila infection confers enhanced antimicrobial activity to macrophages and participates in controlling the infection.
We found that TNF-a can be produced during monocyte infection by L. pneumophila in vitro. Significant induction of TNF-a production, however, was detected only after addition of IFN--y to the infected monocyte culture. It is unclear why significantly increased TNF-ot activity was not detected in the culture supernatants without IFN--y addition even though IL-6 was present. The low sensitivity of the methods used for detection of TNF-ax and the existence of TNF inhibitors and/or receptors may explain our results (6, 19) . Adherent mononuclear cells from three different blood donors were used in our study, and the results obtained were The results obtained with the PTX showed that TNF-a participates in the inhibition of intracellular L. pneumophila multiplication. PTX has been reported to suppress TNF biosynthesis by acting to prevent processing of the primary transcript (8) . PTX and dexamethasone inhibit TNF synthesis by macrophages at various points in the signaling pathway; PTX blocks TNF mRNA transcription, and dexamethasone blocks the TNF mRNA transcription and translation (8, 9) . In contrast to the inhibition of TNF production by PTX, it was reported that this agent has no effect on IL-11 or IL-6 production (5). In our study, PTX did not affect IL-6 RNA levels.
Our results suggest an interaction between TNF-a and IFN--y, since PTX partially abolished the inhibitory effect of IFN-,y. The synergy between TNF-a and IFN--y has been reported in several other studies (10, 12) . IFN--y increases the transcription of TNF-a mRNA in macrophages (4) and increases the number of TNF-a receptors (1, 18) . TNF-a has also been reported to be involved in IFN--y production by natural killer cells (2) . The mechanism by which IFN-y (and TNF-ot) inhibits intracellular bacterial multiplication is not clear, but recent studies have shown that it may be mediated by nitric oxide production (12, 14) . TNF, IFNs, and endotoxin stimulate nitric oxide production by different cells (endothelial cells, leukocytes, macrophages, neutrophils, Kupffer cells, and hepatocytes). The formation of nitric oxide by macrophages was studied essentially in animal models (mouse and rat), but nitric oxide production by human macrophages has been described recently (13) ; we used human macrophages in the present study.
Taken together, our results show that TNF-a is produced during infection of human monocytes by L. pneumophila in vitro and participates in the inhibition of bacterial multiplication in synergy with IFN--y. Whether TNF-a has an immunomodulating role during human infection remains to be established.
